Morgan Stanley Downgrades CSX to Underweight, Maintains Price Target to $30

Benzinga Newsdesk www.benzinga.com Negative 91.6%

Neg 91.6% Neu 0% Pos 0%

Morgan Stanley analyst Ravi Shanker downgrades CSX (NASDAQ:CSX) from Equal-Weight to Underweight and maintains the price target from $30 to $30.